By AuntMinnie.com staff writers

March 12, 2019 -- Genomic medicine company Lucence Diagnostics has launched a joint effort with Stanford University School of Medicine to develop artificial intelligence (AI) algorithms aimed at enhancing the diagnosis and treatment of liver cancer.

The Singapore-based firm said it would be working with Stanford's Olivier Gevaert, PhD, on the project, which will use imaging and molecular data from liver cancer patients to develop software tools that can help physicians make better treatment decisions. Imaging data will be fused with sequencing data that include both cancer mutations and viral DNA, Lucence said.

The team will evaluate a dataset of more than 5,000 patients to identify image changes and patterns that are linked to diagnostic and treatment outcomes in liver cancer, according to the vendor.

Stanford launches huge dataset of chest x-rays for AI
Researchers from Stanford University have released a massive dataset of more than 224,000 chest x-rays to be used for the development of artificial intelligence...
New PET tracer could aid melanoma detection
A new PET tracer designed to target melanin pigment could improve the detection of both primary and metastatic melanoma, according to a study published...
AI could bring ultralow-dose imaging to amyloid PET
With the help of artificial intelligence (AI), researchers have developed a way to generate diagnostic-quality images from PET/MR scans to detect amyloid...
AI may help in fight against gadolinium deposition
An artificial intelligence (AI) algorithm could enable diagnostic-quality MR images to be produced using a fraction of the typical dose of a gadolinium-based...
Machine learning can predict stroke treatment outcomes
Making use of imaging features and demographic information, machine-learning algorithms predicted 90-day outcomes in patients with acute ischemic stroke,...

Copyright © 2019 AuntMinnie.com

Last Updated ks 3/12/2019 10:59:34 AM